loadpatents
name:-0.055391073226929
name:-0.1253490447998
name:-0.0082881450653076
Bao; Rudi Patent Filings

Bao; Rudi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bao; Rudi.The latest application filed is for "egfr inhibitor free base or acid salt polycrystalline form, preparation method therefor, and application".

Company Profile
7.14.30
  • Bao; Rudi - Lianyungang CN
  • BAO; Rudi - Shanghai CN
  • BAO; Rudi - Jiangsu CN
  • Bao; Rudi - Wellesley MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Egfr Inhibitor Free Base Or Acid Salt Polycrystalline Form, Preparation Method Therefor, And Application
App 20220281847 - Chen; Zhongke ;   et al.
2022-09-08
Inhibitor Containing Bicyclic Derivative, Preparation Method Therefor And Use Thereof
App 20220259201 - SU; Yidong ;   et al.
2022-08-18
Anti-bcma Antibody, Antigen-binding Fragment Thereof And Medical Use Thereof
App 20220251228 - HUA; Haiqing ;   et al.
2022-08-11
Nitrogen-containing Heterocyclic Derivative Regulator, Preparation Method Therefor And Application Thereof
App 20220213100 - LIU; Shiqiang ;   et al.
2022-07-07
Multi-receptor Agonist And Medical Use Thereof
App 20220168396 - WU; Fangzhou ;   et al.
2022-06-02
Phosphoinositide 3-kinase Inhibitor With A Zinc Binding Moiety
App 20220168284 - Cai; Xiong ;   et al.
2022-06-02
Fgfr4 Inhibitor And Preparation Method And Use Thereof
App 20220024913 - GAO; Peng ;   et al.
2022-01-27
Steroid Derivative Regulators, Method For Preparing The Same, And Uses Thereof
App 20220017565 - SU; Yidong ;   et al.
2022-01-20
Regulator Of Nitrogen-containing Heteroaromatic Derivatives, Preparation Method Therefor And Use Thereof
App 20210355105 - Liu; Shiqiang ;   et al.
2021-11-18
EGFR inhibitor free base or acid salt polycrystalline form, preparation method therefor, and application
Grant 11,155,534 - Chen , et al. October 26, 2
2021-10-26
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
Grant 11,135,205 - Cai , et al. October 5, 2
2021-10-05
Substituted imidazoles as apoptosis signal regulating kinase 1 inhibitors
Grant 11,136,324 - Gao , et al. October 5, 2
2021-10-05
Tricyclic Derivatives Inhibitor, Preparation Method, And Applications Thereof
App 20210221822 - Gao; Peng ;   et al.
2021-07-22
Steroid Derivative Regulators, Method For Preparing The Same, And Uses Thereof
App 20210139530 - SU; Yidong ;   et al.
2021-05-13
Anti-b7-h4 Antibody, Antigen-binding Fragment Thereof And Pharmaceutical Use Thereof
App 20210032347 - BAO; Rudi ;   et al.
2021-02-04
Amide Derivative Inhibitor And Preparation Method And Application Thereof
App 20210032249 - GAO; Peng ;   et al.
2021-02-04
Egfr Inhibitor Free Base Or Acid Salt Polycrystalline Form, Preparation Method Therefor, And Application
App 20200361909 - CHEN; Zhongke ;   et al.
2020-11-19
EGFR inhibitor free base or acid salt polycrystalline form, preparation method therefor, and application
Grant 10,759,782 - Chen , et al. Sep
2020-09-01
Pyrazolyl-containing Tricyclic Derivative, Preparation Method Therefor And Use Thereof
App 20200247815 - Kind Code
2020-08-06
Phosphoinositide 3-kinase Inhibitor With A Zinc Binding Moiety
App 20200215039 - Cai; Xiong ;   et al.
2020-07-09
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
Grant 10,543,197 - Cai , et al. Ja
2020-01-28
EGFR inhibitor, preparation method and use thereof
Grant 10,428,081 - Wei , et al. October 1, 2
2019-10-01
Fgfr4 Inhibitor, Preparation Method Therefor, And Applications Thereof
App 20190276451 - GAO; Peng ;   et al.
2019-09-12
EGFR inhibitor, preparation method and use thereof
Grant 10,259,820 - Wei , et al.
2019-04-16
Egfr Inhibitor, Preparation Method And Use Thereof
App 20190100528 - WEI; Mingsong ;   et al.
2019-04-04
Phosphoinositide 3-kinase Inhibitor With A Zinc Binding Moiety
App 20190091211 - Cai; Xiong ;   et al.
2019-03-28
Egfr Inhibitor Free Base Or Acid Salt Polycrystalline Form, Preparation Method Therefor, And Application
App 20190077791 - CHEN; Zhongke ;   et al.
2019-03-14
Indoleamine 2,3-dioxygenase Inhibitor, Preparation Method Therefor, And Application
App 20190040025 - WU; Shenghua ;   et al.
2019-02-07
Cholic Acid Derivative, And Preparation Method And Medical Use Thereof
App 20180148470 - LI; Chenghai ;   et al.
2018-05-31
Egfr Inhibitor, Preparation Method And Use Thereof
App 20170313714 - WEI; Mingsong ;   et al.
2017-11-02
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
Grant 9,657,032 - Cai , et al. May 23, 2
2017-05-23
Phosphoinositide 3-kinase Inhibitor With A Zinc Binding Moiety
App 20160185796 - Cai; Xiong ;   et al.
2016-06-30
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
Grant 9,249,156 - Cai , et al. February 2, 2
2016-02-02
Phosphoinositide 3-kinase Inhibitor With A Zinc Binding Moiety
App 20140243330 - Cai; Xiong ;   et al.
2014-08-28
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
Grant 8,710,219 - Cai , et al. April 29, 2
2014-04-29
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety
Grant 8,518,910 - Cai , et al. August 27, 2
2013-08-27
Treatment Of Cancers Having K-ras Mutations
App 20130102595 - Bao; Rudi ;   et al.
2013-04-25
Phosphoinositide 3-kinase Inhibitor With A Zinc Binding Moiety
App 20130090335 - Cai; Xiong ;   et al.
2013-04-11
Formulation Of Quinazoline Based Egfr Inhibitors Containing A Zinc Binding Moiety
App 20120122881 - Cai; Xiong ;   et al.
2012-05-17
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety
Grant 8,119,616 - Cai , et al. February 21, 2
2012-02-21
Formulation Of Quinazoline Based Egfr Inhibitors Containing A Zinc Binding Moiety
App 20090111772 - Cai; Xiong ;   et al.
2009-04-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed